drugset / Trial / NCT07421375
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015-A and co-administration of BR1015-1 and BR1015-2 in healthy volunteers under fasting conditions
Timeline
- Start
- 2026-04-02
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BR1015-1 | Unknown | — | Oral |
| Comparator | BR1015-2 | Unknown | — | Oral |
| Subject | BR1015-A | Unknown | — | Oral |